Global Duchenne Muscular Dystrophy Market Status and Outlook 2018-2025

August 2018 | 117 pages | ID: G7C90FB8607EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• PTC Therapeutics
• Sarepta Therapeutics
• Bristol-Myers Squibb
• ITALFARMACO
• BioMarin
• Daiichi Sankyo
• Solid Biosciences
• Summit Therapeutics
• FibroGen
• NS Pharma
• Pfizer
• ReveraGen BioPharma
• Wave Life
• Genethon
• Santhera Pharmaceuticals

Market by Type

• Deflazacort
• Prednisone
• Others

Market by Application

• Male
• Female

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Duchenne Muscular Dystrophy Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Deflazacort
  3.1.2 Prednisone
  3.1.3 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Male
  4.1.2 Female
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Deflazacort Production by Region
    6.1.1.2 Prednisone Production by Region
    6.1.1.3 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Male Production by Region
    6.1.2.2 Female Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Deflazacort Demand by Region
    6.2.1.2 Prednisone Demand by Region
    6.2.1.3 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Male Demand by Region
    6.2.2.2 Female Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 PTC Therapeutics
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Sarepta Therapeutics
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Bristol-Myers Squibb
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 ITALFARMACO
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 BioMarin
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Daiichi Sankyo
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Solid Biosciences
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Summit Therapeutics
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 FibroGen
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 NS Pharma
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Pfizer
8.12 ReveraGen BioPharma
8.13 Wave Life
8.14 Genethon
8.15 Santhera Pharmaceuticals

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Duchenne Muscular Dystrophy Industry Dynamics & Regulations List
Table Global Duchenne Muscular Dystrophy Sales Revenue, Cost and Margin, 2015-2018E
Table Global Duchenne Muscular Dystrophy Market Status by Type 2015-2018E, in USD Million
Table Global Duchenne Muscular Dystrophy Market Status by Application 2015-2018E, in USD Million
Table Global Duchenne Muscular Dystrophy Market Status by Application 2015-2018E, in Volume
Table Global Duchenne Muscular Dystrophy Market by Region 2015-2018E, in USD Million
Table Global Duchenne Muscular Dystrophy Market Share by Region in 2018, in USD Million
Table Global Duchenne Muscular Dystrophy Market by Region 2015-2018E, in Volume
Table Global Duchenne Muscular Dystrophy Market Share by Region in 2018, in Volume
Table Deflazacort Production Value by Region 2015-2018E, in USD Million
Table Deflazacort Production Volume by Region 2015-2018E, in Volume
Table Prednisone Production Value by Region 2015-2018E, in USD Million
Table Prednisone Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Male Production Value by Region 2015-2018E, in USD Million
Table Male Production Volume by Region 2015-2018E, in Volume
Table Female Production Value by Region 2015-2018E, in USD Million
Table Female Production Volume by Region 2015-2018E, in Volume
Table Deflazacort Market Size by Region 2015-2018E, in USD Million
Table Deflazacort Market Size by Region 2015-2018E, in Volume
Table Prednisone Market Size by Region 2015-2018E, in USD Million
Table Prednisone Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Male Market Size by Region 2015-2018E, in USD Million
Table Male Market Size by Region 2015-2018E, in Volume
Table Female Market Size by Region 2015-2018E, in USD Million
Table Female Market Size by Region 2015-2018E, in Volume
Table GlobalDuchenne Muscular Dystrophy Forecast by Type 2019F-2025F, in USD Million
Table Duchenne Muscular Dystrophy Forecast by Type 2019F-2025F, in Volume
Table Duchenne Muscular Dystrophy Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Duchenne Muscular Dystrophy Market Forecast by Region 2019F-2025F, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast by Region 2019F-2025F, in Volume
Table PTC Therapeutics Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of PTC Therapeutics
Table Sarepta Therapeutics Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Sarepta Therapeutics
Table Bristol-Myers Squibb Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Bristol-Myers Squibb
Table ITALFARMACO Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of ITALFARMACO
Table BioMarin Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of BioMarin
Table Daiichi Sankyo Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Daiichi Sankyo
Table Solid Biosciences Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Solid Biosciences
Table Summit Therapeutics Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Summit Therapeutics
Table FibroGen Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of FibroGen
Table NS Pharma Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of NS Pharma
Table Pfizer Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Pfizer
Table ReveraGen BioPharma Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of ReveraGen BioPharma
Table Wave Life Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Wave Life
Table Genethon Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Genethon
Table Santhera Pharmaceuticals Information
Table Duchenne Muscular Dystrophy Sales, Cost, Margin of Santhera Pharmaceuticals
Table Global Duchenne Muscular Dystrophy Sales Revenue by Company 2015-2017, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume by Company 2015-2017, in Volume
Table Global Duchenne Muscular Dystrophy Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Duchenne Muscular Dystrophy Picture
Figure Duchenne Muscular Dystrophy Industry Chain Diagram
Figure Global Duchenne Muscular Dystrophy Sales Revenue 2015-2018E, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Volume 2015-2018E, in Volume
Figure Global Duchenne Muscular Dystrophy Market Status by Type 2015-2018E, in Volume
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure Middle East Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in USD Million
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2018E, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Price Forecast 2019F-2025F
Figure Global Duchenne Muscular Dystrophy Gross Margin Forecast 2019F-2025F
Figure Global Duchenne Muscular Dystrophy Sales Revenue by Company in 2018, in USD Million
Figure Global Duchenne Muscular Dystrophy Price by Company in 2018
Figure Global Duchenne Muscular Dystrophy Gross Margin by Company in 2018